A Patient’s Existential Angst
Healthcare, as we see it, is defined through broad statistics. For the patient, healthcare is the unique day to day...
Hidden Flaw in Observational Studies
One way in which observational studies can be manipulated is by playing with the time horizon of the study data.
Let’s Measure Patient Virality
We're spearheading a unique initiative to study the component elements of how patient stories become viral.
A Call to Study MCAT Implicit Bias
We will soon begin the initial cohort of students who will learn how to analyze MCAT exam structure and syntax.
Endorse Barby Ingle!
Barby Ingle is the ideal candidate for the position of Arizona State Representative District 7. We endorse her nomination!
Getting a Colonoscopy in Prison
Incarcerated individuals find themselves caught in an intricate web of inadequate healthcare and limited access to screening tests.
Rise of Cash Pay Drugs
With medication costs surpassing household incomes, a growing number of individuals are exploring alternative ways to access medicines.
Extreme Weather Fluctuations Affect Medically Vulnerable
How do extreme weather fluctuations affect patients' health and chronic conditions, particularly among the elderly and immunocompromised?
Extreme Cold is Bad for your Health
Prolonged exposure to freezing temperatures can lead to serious health conditions, with hypothermia being the most immediate concern.
Patient Social Networks
A patient's social network is often a literal life line for improving patient compliance and long term outcomes.
Tracking the 2023-2024 Flu Season
From October 1, 2023, through December 30, 2023, the CDC tracked flu-related cases that have impacted public health.
The Fault in Our Tests
We share our proposal to collaborate with the AAMC to study the nature of implicit biases in the MCAT and...
Videos
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more